Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.45 USD | -3.76% |
|
+7.51% | +7.23% |
08/07 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
01/07 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.23% | 198M | |
+22.15% | 46.56B | |
+45.43% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug